The COVID-19 pandemic boosted uptake and acceptance of the benefits of electronic prescribing, but also highlighted some of the technical deficiencies in existing systems, a University of Otago study has found.

Published in The New Zealand Journal of Primary Healthcare, the study surveyed over 160 New Zealand GPs, practice nurses and nurse practitioners over a period of 16 weeks from May last year, examining how they dealt with the pandemic-induced change to electronic patient prescriptions.